Waystar Holding Corp. logo WAY - Waystar Holding Corp.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
1
BUY 16
HOLD 1
SELL 0
STRONG
SELL
0
| PRICE TARGET: $32.89 DETAILS
HIGH: $39.00
LOW: $28.00
MEDIAN: $33.00
CONSENSUS: $32.89
UPSIDE: 14.64%

Stock News

New Waystar and Modern Healthcare Research Reveals Significant Gaps in Providers' Ability to Prevent Payer Recoupments

New Waystar and Modern Healthcare Research Reveals Significant Gaps in Providers' Ability to Prevent Payer Recoupments

Study finds 42% of hospitals and health systems face at least $1 million in annual recoupment requests, as new research highlights growing demand for AI-powered automation LEHI, Utah and LOUISVILLE, Ky., Oct. 22, 2026 /PRNewswire/ -- Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, and Modern Healthcare today announced new research showing that payer recoupments create significant financial exposure, drain staff capacity, and make it harder for healthcare organizations to protect revenue after payment.

Oct 22, 2026 05:00 AM • prnewswire.com
WAYSTAR INVESTOR ALERT: Kaskela Law Firm Announces Stockholder Investigation of Waystar Holding Corp. (WAY) and Encourages Investors to Contact the Firm to Explore Their Legal Rights and Options

WAYSTAR INVESTOR ALERT: Kaskela Law Firm Announces Stockholder Investigation of Waystar Holding Corp. (WAY) and Encourages Investors to Contact the Firm to Explore Their Legal Rights and Options

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law announces that it is investigating Waystar Holding Corp. (NASDAQ: WAY) (“Waystar”) on behalf of the company's stockholders.Click here to request additional information: https://kaskelalaw.com/case/waystar-holding-corp/The investigation seeks to determine whether Waystar and/or the company's officers and directors violated the securities laws or breached their fiduciary duties in connection with recent corporate actions.Waystar stockholders are encourage.

Sep 22, 2026 04:01 AM • businesswire.com (Hide legal announcements)
Waystar: Subscription Growth And AI Expansion Justify The Buy Position

Waystar: Subscription Growth And AI Expansion Justify The Buy Position

Waystar Holding earns a buy rating for its compelling mix of 18% revenue growth, 34% subscription growth, and 42.8% adjusted EBITDA margin. WAY's expanding AI capabilities and the Iodine Software acquisition enhance platform value, drive cross-selling, and increase the addressable market by over 15%. Subscription revenue and net revenue retention of 108% underscore a stable, recurring revenue base with strong client expansion and upselling.

Sep 10, 2026 05:15 AM • seekingalpha.com
Waystar Launches New Agentic Solutions Transforming AI Into Action Across the Revenue Cycle

Waystar Launches New Agentic Solutions Transforming AI Into Action Across the Revenue Cycle

Waystar AltitudeAI™ innovations autonomously execute work, connect intelligence to action, and realize significant outcomes for providers LEHI, Utah and LOUISVILLE, Ky., Aug. 26, 2026 /PRNewswire/ -- Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, today unveiled new Waystar AltitudeAI-powered agentic capabilities that autonomously take action across critical revenue cycle workflows, advancing the company's vision for an autonomous revenue cycle.

Aug 26, 2026 07:21 AM • prnewswire.com
Waystar Expands Executive Leadership to Accelerate Innovation and Growth

Waystar Expands Executive Leadership to Accelerate Innovation and Growth

Appointments extend world-class technology expertise and commercial leadership to advance Waystar's vision for the autonomous revenue cycle LEHI, Utah and LOUISVILLE, Ky., Aug. 25, 2026 /PRNewswire/ -- Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, today announced two executive leadership appointments designed to accelerate innovation, client adoption, and durable growth.

Aug 25, 2026 02:37 PM • prnewswire.com

Price Targets